This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Calla Therapeutics LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jaber Qasem: Innovator in Transdermal Delivery Systems
Introduction
Jaber Qasem is an inventive mind based in the United States, known for his contributions to the field of transdermal drug delivery. His work primarily focuses on topical formulations that enhance the delivery of niacin, a vital compound for managing lipid profiles in humans.
Latest Patents
Jaber Qasem holds a patent titled "Topical Formulations For The Transdermal Delivery Of Niacin And Methods Of Treating Hyperlipidemia." This innovative patent outlines methods for administering niacin and its prodrugs through the skin, aiming to improve lipid profiles effectively.
Career Highlights
Throughout his career, Jaber Qasem has worked with notable organizations, including Niadyne, Inc. and the University of Kentucky Research Foundation. His experience in these institutions has allowed him to develop and refine his innovative approaches to drug delivery.
Collaborations
Jaber has collaborated with esteemed colleagues such as Myron K Jacobson and Hyuntae Kim, contributing to advancements in his field through shared expertise and innovative ideas.
Conclusion
Jaber Qasem's work in transdermal delivery systems represents a significant advancement in the treatment of hyperlipidemia. His innovative approaches and collaborations continue to influence the field of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile